Study guide

1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

Key Takeaways Explain This Topic AI

DOPL may inspect a licensed pharmacy during regular business hours, examine records, take samples, and temporarily seize suspected adulterated, misbranded, or outdated drugs (Utah Code § 58-17b-103).

A pharmacy must notify DOPL in writing at least 10 business days before a closure, change of ownership, change of name, or change of location (Utah Code § 58-17b-614).

A request to change a pharmacy's address must be received at least 90 days before operation at the new address begins (Utah Code § 58-17b-306(3); R156-17b-618(3)).

Within 10 days after a pharmacy closes, DOPL must receive a surrender notice attesting to the closing inventory and the transfer of prescription files (R156-17b-604(5)).

A DOPL citation may impose a fine of up to $10,000 per violation or $2,000 per day of ongoing violation and must be contested within 20 calendar days (Utah Code § 58-17b-504(5)).

Last updated: September 2026

1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

The MPJE blueprint covers the full life cycle of a licensed practice setting: licensure, renewal and reinstatement, inspection, and discipline. Section 1.3 covered the license classes. This section covers what happens after a pharmacy is licensed.

Administrative inspections (§ 58-17b-103)

DOPL may, to check compliance, require a self-audit or enter and inspect the business premises of a licensee (or of a person doing work that requires a license).

Before inspecting, DOPL must identify the person in charge and then:

  • give proper identification;
  • ask to see the applicable license;
  • describe the nature and purpose of the inspection; and

on request, state its authority to inspect and the penalty for refusing.

During the inspection DOPL may examine any record, prescription, order, drug, device, equipment, or electronic media; copy records at its own cost; take a drug or device for analysis; temporarily seize a drug or device suspected to be adulterated, misbranded, outdated, or otherwise in violation, pending an adjudicative proceeding; box and seal suspect drugs; and dispose of or return seized items under division rule (R156-17b-103).

Inspections must be conducted during regular business hours (§ 58-17b-103(4)).

If DOPL concludes that a violation occurred and discipline is appropriate, the director or designee promptly issues a fine or citation (§ 58-17b-103(5)).

Knowingly refusing to permit an inspection is unlawful conduct (§ 58-17b-501(1)). Failing to comply with an inspection, and failing to correct operating-standard violations within the time DOPL sets, are unprofessional conduct (R156-17b-502(7), (10)).

Controlled substance licensees must make CS stock, records, and facilities available for inspection during regular business hours and at other reasonable times (R156-37-601).

Required notices (§ 58-17b-614)

A pharmacy must report to DOPL in writing at least 10 business days before :

  • a permanent closure;
  • a change of business name or ownership;
  • a change of location;
  • a sale or transfer of controlled substances because of a closure or ownership change; or

any other event DOPL requires by rule.

A Class D pharmacy must also report, within 10 business days after it is issued, any final disciplinary order against the pharmacy or its PIC by its home state. A pharmacy must report immediately any disaster, accident, or emergency that may affect the purity or labeling of drugs. Copies of these notices must be kept for two years .

Ownership, name, and address changes (R156-17b-618)

Change Requirement

Qualifying ownership change Apply for a new license and receive DOPL approval at least 10 business days before the change; surrender the original license when the new one is issued

Name change without an ownership change Request received at least 10 business days before the effective date (including adding or dropping a DBA)

Address change without an ownership change Request received at least 90 days before operating at the new address (§ 58-17b-306(3)); R156-17b-618(3) says 90 business days; an in-state move includes a request for inspection of the new site

A qualifying change of ownership also requires an inventory of legend drugs and controlled substances on the date of the change. That inventory is the seller's closing inventory and the buyer's initial inventory, and any Schedule I or II transfer uses a DEA Form 222 (R156-17b-605(5)).

Closing a pharmacy (R156-17b-604)

Follow the DEA rules for discontinuing or transferring a business (21 CFR 1301.52) and for Form 222 handling.

If the pharmacy dispenses prescriptions, post a closing notice at the prescription department and the public entrances, giving the closing date and the name, address, and phone number of the pharmacy that will hold the prescription files.

On the closing date, remove all prescription drugs by returning them to the manufacturer or supplier, or by transferring, selling, or giving them to a person legally entitled to possess them.

Transfer prescription files, refill information, and patient profiles to a licensed pharmacy within a reasonable distance. Remove "pharmacy" signs, or notify the landlord that using the word at that address is unlawful.

Within 10 days after closing, send DOPL a surrender notice giving the closing date, surrendering the license, attesting that a closing inventory was taken and how drugs were disposed of or transferred, and naming the pharmacy that received the files.

If the pharmacy closes suddenly (fire, natural disaster, death, seizure, eviction, bankruptcy), these steps are done as far in advance as circumstances allow. If the PIC is unavailable, the owner or legal representative is responsible.

Renewal and reinstatement of the facility license

Pharmacy licenses run on a two-year cycle that ends September 30 of odd-numbered years (R156-1-308a). DOPL sends a renewal notice at least 60 days before expiration, and a license not renewed by its expiration date expires automatically (R156-1-308c). A Class D pharmacy that compounds must submit an inspection report conducted within the prior two years to renew (§ 58-17b-308(4)).

Discipline of a pharmacy

A pharmacy license can be denied, refused renewal, revoked, suspended, restricted, placed on probation, or reprimanded under § 58-17b-401 and § 58-1-401 . DOPL can also act through citations under § 58-17b-504(5) :

A citation may assess a fine of up to $10,000 per single violation or up to $2,000 per day of ongoing violation, whichever is greater, following the fine schedule in R156-17b-402, and may include a cease and desist order.

Other license sanctions (suspension, revocation, probation) cannot be imposed through a citation.

The recipient must notify DOPL in writing within 20 calendar days of service to contest it. Otherwise the citation becomes the final order and is not subject to further agency review.

No citation may be issued more than one year after the violation is reported to DOPL.

More generally, DOPL must start discipline within four years after conduct is reported, and not more than 10 years after it occurred, except for proceedings responding to a civil or criminal judgment or settlement (§ 58-1-401(6)).

Fines fund pharmacy licensee education and enforcement (§ 58-17b-505). Examples from R156-17b-402: a pharmacy that fails to offer counseling faces $2,000 per occurrence ; buying or selling drug samples carries $1,000–$5,000 for a first offense and $10,000 for a subsequent one.